Analysis of data from the 2017 @GlobalDrugSurvy suggests #psilocybin is a relatively safe drug
Only 0.2% of users sought emergency medical care after use, and the majority of those had combined the #psychedelic with another drug e.g. #cannabis or #alcohol
https://t.co/5LNnbCB2h5
Learn how genetics can impact your #psychedelic response. From a cheek swab, we provide rapid #DNA test results within days.
Get access to pre-screening surveys & educational resources to help you gain key insights into your psychedelic journey.
#psychedelictherapy#genetictest
The NRG1 gene is a promising factor for differentiating high-risk individuals who are at risk for psychosis.
NRG1 genotype can provide insight into risk for early onset psychosis and the potential for adverse drug reactions when using #psychedelic drugs.
HaluGen’s genetic test helps to evaluate your overall sensitivity and risk profile when using psychedelic drugs.
View your results along with screening surveys, research papers & educational resources to help you gain key insights into your psychedelic journey.
#psychedelics
The way your body metabolizes #ketamine, a fast-acting anesthetic with #hallucinogenic properties, is influenced by the CYP2B6 gene.
10–20% of people carry the CYP2B6*6 genetic variant which causes them to metabolize ketamine up to 2x to 3x slower than normal.
#psychedelics
Interested in discovering how you’ll potentially respond to psychedelics?
Order your test today and discover how your genetics can affect your psychedelic experience.
#psychedelics#genetics#psychedelictherapy
HaluGen's Psychedelics Genetic Test Kit now includes a key pharmacodynamic biomarker, the brain-derived neurotrophic factor (BDNF) gene.
Read the full press release here - https://t.co/MlXfyCyVBD
#ketamine#ketaminetherapy#psychedelictherapy